These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Modulation of the host response in the treatment of periodontitis. Golub LM; Ryan ME; Williams RC Dent Today; 1998 Oct; 17(10):102-6, 108-9. PubMed ID: 10752438 [TBL] [Abstract][Full Text] [Related]
5. Host response modulation in the management of periodontal diseases. Salvi GE; Lang NP J Clin Periodontol; 2005; 32 Suppl 6():108-29. PubMed ID: 16128833 [TBL] [Abstract][Full Text] [Related]
6. Using host response modifiers in the treatment of periodontal disease. Novak MJ; Donley TG Pract Proced Aesthet Dent; 2002; 14(9):suppl 3-10; quiz 11. PubMed ID: 12685424 [TBL] [Abstract][Full Text] [Related]
7. Host modulation as a therapeutic strategy in the treatment of periodontal disease. Kornman KS Clin Infect Dis; 1999 Mar; 28(3):520-6. PubMed ID: 10194070 [TBL] [Abstract][Full Text] [Related]
9. Paradigm shift in the pharmacological management of periodontal diseases. Hasturk H; Kantarci A; Van Dyke TE Front Oral Biol; 2012; 15():160-76. PubMed ID: 22142963 [TBL] [Abstract][Full Text] [Related]
10. Host modulation for the treatment of periodontal disease. Williams RC Compend Contin Educ Dent; 2008 Apr; 29(3):160-2, 164, 166-8 passim. PubMed ID: 18468302 [TBL] [Abstract][Full Text] [Related]
11. Can systemic diseases co-induce (not just exacerbate) periodontitis? A hypothetical "two-hit" model. Golub LM; Payne JB; Reinhardt RA; Nieman G J Dent Res; 2006 Feb; 85(2):102-5. PubMed ID: 16434727 [No Abstract] [Full Text] [Related]
12. Lipoxins and new lipid mediators in the resolution of inflammation. Schwab JM; Serhan CN Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421 [TBL] [Abstract][Full Text] [Related]
13. Modulation of the host response in periodontal therapy. Oringer RJ; J Periodontol; 2002 Apr; 73(4):460-70. PubMed ID: 11990448 [TBL] [Abstract][Full Text] [Related]
14. Rheumatoid arthritis and periodontitis: biological links and the emergence of dual purpose therapies. Modi DK; Chopra VS; Bhau U Indian J Dent Res; 2009; 20(1):86-90. PubMed ID: 19336867 [TBL] [Abstract][Full Text] [Related]
15. The management of inflammation in periodontal disease. Van Dyke TE J Periodontol; 2008 Aug; 79(8 Suppl):1601-8. PubMed ID: 18673016 [TBL] [Abstract][Full Text] [Related]
16. Proresolving lipid mediators: potential for prevention and treatment of periodontitis. Van Dyke TE J Clin Periodontol; 2011 Mar; 38 Suppl 11():119-25. PubMed ID: 21323709 [TBL] [Abstract][Full Text] [Related]
17. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. Van Dyke TE; Serhan CN J Dent Res; 2003 Feb; 82(2):82-90. PubMed ID: 12562878 [TBL] [Abstract][Full Text] [Related]
18. Proresolution mediators and receptors: novel drug targets for enhancing pharmacological armamentarium against periodontal inflammation. Grover V; Malhotra R; Kapoor A; Singh J; Sachdeva S Infect Disord Drug Targets; 2013 Feb; 13(1):75-84. PubMed ID: 23713671 [TBL] [Abstract][Full Text] [Related]
19. [Proinflammatory cytokines in pathogenesis of periodontal disease]. Malkowska A; Kasprzak A; Stopa J Pol Merkur Lekarski; 2006 Jan; 20(115):93-8. PubMed ID: 16617746 [TBL] [Abstract][Full Text] [Related]
20. Modulation of the host inflammatory response in periodontal disease management: exciting new directions. Bhatavadekar NB; Williams RC Int Dent J; 2009 Oct; 59(5):305-8. PubMed ID: 19998666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]